中文 | English
Return
Total: 6 , 1/1
Show Home Prev Next End page: GO
Author:( Jiehao LIU)

1.Advances of peptides in cancer treatment

Ziqiang ZHANG ; Xiaofeng YANG ; Jiehao LIU

Journal of International Oncology 2015;42(1):52-55

2.Preclinical study of bladder cancer diagnosis using tumor homing peptide fluorescent molecular probe

Xiaofeng YANG ; Yang ZHAO ; Xinyou JIA ; Jun LI ; Rengxin LIU ; Wei WANG ; Jiehao LIU ; Zhenwei FAN

Chinese Journal of Urology 2015;(6):463-467,468

3.Selection of peptide specifically binding to bladder carcinoma by using phage display in vivo

Junqian LUO ; Fan ZHANG ; Xiaofeng YANG ; Fang LUO ; Jiehao LIU ; Jianzhi PANG ; Sanhua YAN ; Xiaolei ZHANG

Chinese Journal of Immunology 2015;(4):509-513

4.Experimental study on the characters of the FITC-CSNRDARRC molecular probe and its targeted ability for orthotopic transplanted tumor of bladder cancer in vivo

Sanhua YAN ; Jianzhi PANG ; Xiaofeng YANG ; Jiehao LIU ; Ziqiang ZHANG ; Fan ZHANG ; Junqian LUO

Chinese Journal of Urology 2015;36(9):699-704

5.Correlation analysis of ERCC1 and BRCA1 gene polymorphism and non -small cell lung cancer platinum chemotherapy drugs sensitivity and chemotherapy prognosis

Mingcong CHEN ; Jiehao XUE ; Huibin JIANG ; Yan SHANG ; Guifen HE ; Shuxun LIU

Chinese Journal of Primary Medicine and Pharmacy 2016;23(16):2401-2404,2405

6.Exploring the hemodynamic changes of the ascending aorta before and after interventricular septal myocardial resection in obstructive hypertrophic cardiomyopathy by CMR 4D Flow technology

Xinyi LUO ; Guanyu LU ; Jiehao OU ; Yuelong YANG ; Liqi CAO ; Zhigang WU ; Jinglei LI ; Hui LIU

Journal of Chinese Physician 2024;26(1):25-30

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 6 , 1/1 Show Home Prev Next End page: GO